QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 30 May 2006
doi: 10.1242/jcs.02966

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.02966v1 119/12/2583    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S. W. Articles by Zetter, B. R. Search for Related Content PubMed PubMed Citation Articles by Kim, S. W. Articles by Zetter, B. R. Social Bookmarking                         What's this?

Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism

¹ Program in Vascular Biology and Department of Surgery, Children's Hospital, Boston, MA 02115, USA
² Department of Psychiatry, Düsseldorf University, 40225 Düsseldorf, Germany
³ Department of Cellular and Molecular Physiology, Pennsylvania State College of Medicine, Hershey, PA 17033, USA

^* Author for correspondence (e-mail: bruce.zetter{at}childrens.harvard.edu)

Accepted 23 March 2006

The antizyme inhibitor was discovered as a protein that binds to the regulatory protein antizyme and inhibits the ability of antizyme to interact with the enzyme ornithine decarboxylase (ODC). Blocking antizyme activity subsequently leads to increased intracellular levels of ODC and increased ODC enzymatic activity. We now report that antizyme inhibitor is a positive modulator of cell growth. Overexpression of antizyme inhibitor in NIH-3T3 mouse fibroblasts or in AT2.1 Dunning rat prostate carcinoma cells resulted in an increased rate of cell proliferation and an increase in saturation density of the cultured cells. This was accompanied by an increase in intracellular levels of the polyamine putrescine. In AT2.1 cells, antizyme inhibitor overexpression also increased the ability of the cells to form foci when grown under anchorage-independent conditions. In order to determine the role of antizyme on antizyme inhibitor activity we created an antizyme inhibitor mutant, AZI_117-140, which lacks the putative antizyme-binding domain. We show that this mutant fails to bind to antizyme, but remains capable of inducing increased rates of cell proliferation, suggesting that antizyme inhibitor has antizyme-independent functions. Silencing antizyme inhibitor expression leads to diminished levels of cyclin D1 and to reduced cell proliferation. Antizyme inhibitor is capable of preventing cyclin D1 degradation, and this effect is at least partially independent of antizyme. We show that wild-type antizyme inhibitor and the AZI_Y mutant are capable of direct interaction with cyclin D1 suggesting a potential mechanism for the antizyme-independent effects. Together, our data suggest a novel function for antizyme inhibitor in cellular growth control.

Key words: Antizyme inhibitor, Proliferation, Cyclin D1, Growth regulation, Ornithine decarboxylase, Neoplasm, Polyamine

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C.-P. Liao, M. E. Lasbury, S.-H. Wang, C. Zhang, P. J. Durant, Y. Murakami, S. Matsufuji, and C.-H. Lee Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages J. Biol. Chem., March 20, 2009; 284(12): 8174 - 8184. [Abstract] [Full Text] [PDF]

				W. Arap, M. Trepel, B. R. Zetter, and R. Pasqualini Meeting Report: Innovations in Prostate Cancer Research Cancer Res., February 1, 2008; 68(3): 635 - 638. [Full Text] [PDF]